PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Clinical trials for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME trials appear
Sign up with your email to follow new studies for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an IV drug ease sudden OCD in kids? new study tests panzyga
Disease control CompletedThis study tested whether Panzyga, a medicine given through a vein, can reduce obsessive-compulsive symptoms in children aged 6 to 17 with PANS/PANDAS. The trial compared Panzyga to a placebo over 9 weeks. The main goal was to see if symptoms improved more with Panzyga than with …
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Hidden costs of childhood brain inflammation revealed in new survey
Knowledge-focused CompletedThis completed study surveyed 65 people with PANS or PANDAS (or their parents) to understand how IVIG treatment impacts family finances, parents' ability to work, and children's school attendance. The goal is to describe the economic and quality-of-life effects of treating—or not…
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC